B. Formby et R. Stern, PHOSPHORYLATION STABILIZES ALTERNATIVELY SPLICED CD44 MESSENGER-RNA TRANSCRIPTS IN BREAST-CANCER CELLS - INHIBITION BY ANTISENSE COMPLEMENTARY TO CASEIN KINASE-II MESSENGER-RNA, Molecular and cellular biochemistry, 187(1-2), 1998, pp. 23-31
CD44, the predominant vertebrate cell surface receptor for hyaluronan,
exists in a variety of isoforms resulting from alternative splicing o
f a single gene. Particular spliced variants of CD44 correlate with in
creased cell motility, and with poor clinical prognosis in several kin
ds of carcinomas. Combinations of 9 variant exons that confer this enh
anced motility on tumor cells are inserted into a single site in the m
iddle of the extracellular domain of CD44. Evidence suggests that phos
phorylation of 2 serine residues in the intracellular domain of CD44 a
re involved in controlling these events. However, evidence is lacking
as to the nature of such kinases. Acidic amino acids in close proximit
y to these 2 serine residues suggests casein kinase II (CKII) is invol
ved. We now show an antisense phosphorothioate oligonucleotide designe
d to hybridize to the AUG translation initiation codon of subunit CKII
alpha' mRNA blocks in vivo phosphorylation of CD44 in MDA231 breast t
umor cells, and at the protein level decreases ectopic expression of t
otal CD44 as well as the metastatic v-7 CD44 isoform. Furthermore subp
lateau RT-PCR analysis demonstrated antisense transfected MDA231 tumor
cells had significant down-regulated or eliminated mRNA transcripts o
f metastatic CD44 isoforms. CKII as a CD44-associated serine kinase th
erefore may serve as an important molecule in a signaling cascade that
produces a variety of cellular responses in MDA231 breast cancer cell
s. Since the 3'-untranslated region of CD44 mRNA contain 4 dispersed A
UUUA sequences which serve as signals targeting mRNA for rapid turnove
r, a mechanism is proposed by which CD44 phosphorylation mediates labi
le message stabilization, hence providing insights into the processes
involved in cancer cell growth, invasion and metastasis.